.jpg)
Digoxin Immune-Fab [(Duck IgY(ΔFc)]: Treatment of Digoxin toxicity and severe preeclampsia. The technology breakthroughs the current production barrier and with the capability to produce millions of vials of anti-Digoxin IgY(ΔFc)-Fab per year.
More information about Digoxin Specific IgY(ΔFc)-Fab.
If you are interested in exploring partnering with us to advance this exciting project, contact us at partnership@good-biotech.com
